SA
DMRA logo
Damora Therapeutics, Inc.(DMRA)
Closing price · checked 8:21 PM ETAbout this dataData status
$23.22▼-1.08 (-4.44%)
Extended:$23.22+0.00 (+0.00%)· 8:21 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Damora Therapeutics, Inc. (DMRA)

Tangible Book Value Per Share

8.02

TTM · Retrieved:

DMRA logo

DMRA Tangible Book Value Per Share

Current (TTM)8.02
DMRA Tangible Book Value per Share (30.14 → 8.02)
High-resolution chart · PNG

What is tangible book value per share?

Tangible equity divided by shares outstanding.

DMRA tangible book value per share history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Damora Therapeutics, Inc. Tangible Book Value Per Share — Annual fiscal periods
Period endingTangible Book Value Per ShareChange
176.3603+1,310.24%
12.5057−58.89%
30.4186−49.94%
60.7587−47.63%
116.008−29.17%
163.7738+243.76%
47.6415+58.09%
30.1353—

Frequently asked questions: DMRA tangible book value per share

What is Damora Therapeutics, Inc. (DMRA)'s current tangible book value per share?

Damora Therapeutics, Inc. (DMRA)'s latest reported tangible book value per share (TTM) is 8.02 as of Nov 21, 2026. Tangible equity divided by shares outstanding.

How much historical tangible book value per share data is available for DMRA?

Stock Alarm Pro provides 8 dated annual fiscal periods observations for Damora Therapeutics, Inc. (DMRA)'s tangible book value per share, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare DMRA's tangible book value per share to peers or set an alert?

You can open DMRA's tangible book value per share in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on DMRA delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.